MSLN and neoplasm: Future studies correlating serum mesothelin with detailed clinical information, such as tumour stage, tumour bulk, and response to treatment, will also have to be done to determine if serum mesothelin has prognostic significance and also if it can be used as a biomarker to assess response to other therapies besides surgery [17].